Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.

Rikke B HolmstrømDitte V MogensenJørn BrynskovMark A AinsworthJacob NerstingKjeld SchmiegelowCasper Steenholdt

Published in: Digestive diseases and sciences (2018)

Effectiveness of ADL therapy associated with circulating ADL levels and anti-ADL Ab formation. In this study, there appeared no direct interactions between thiopurine metabolites and ADL or anti-ADL Abs.

Keyphrases

patients with inflammatory bowel disease
rheumatoid arthritis
ms ms
ulcerative colitis
randomized controlled trial
juvenile idiopathic arthritis
stem cells
mesenchymal stem cells